Global regulatory progress in delivering on the promise of gene therapies for unmet medical needs

Molecular Therapy - Methods & Clinical Development - Tập 21 - Trang 524-529 - 2021
Daniela Drago1, Betsy Foss-Campbell2, Keith Wonnacott3, David Barrett4, Adora Ndu5
1Biogen, Inc., Global Safety and Regulatory Sciences, Cambridge, MA, USA
2American Society of Gene and Cell Therapy, Policy and Advocacy, Milwaukee, WI, USA
3Pfizer, Inc., Global Regulatory Affairs, Gaithersburg, MD, USA
4American Society of Gene and Cell Therapy, Executive Office, Milwaukee, WI, USA
5BioMarin Pharmaceutical, Inc., Worldwide Research and Development Strategy, Scientific Collaborations and Policy, Washington, DC, USA

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Molecular Therapy - Methods & Clinical Development

Tập 21

524-529

Thông tin tác giả